US 9937192
Combination therapy to treat mycobacterium diseases
granted A61KA61K31/132A61K31/34
Quick answer
US patent 9937192 (Combination therapy to treat mycobacterium diseases) held by SPERO TRINEM, INC. expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SPERO TRINEM, INC.
- Grant date
- Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/132, A61K31/34, A61K31/4164, A61K31/4168